P. Gaitonde Et Al. , "COST-EFFECTIVENESS ANA LYSIS OF SOFOSBUVIR BASED COMBINATION THERAPIES AMONG TREATMENT-NAIVE AND PRE-TREATED PATIENTS WITH HEPATITIS C INFECTION," VALUE IN HEALTH , vol.18, no.3, 2015
Gaitonde, P. Et Al. 2015. COST-EFFECTIVENESS ANA LYSIS OF SOFOSBUVIR BASED COMBINATION THERAPIES AMONG TREATMENT-NAIVE AND PRE-TREATED PATIENTS WITH HEPATITIS C INFECTION. VALUE IN HEALTH , vol.18, no.3 .
Gaitonde, P., Yerlikaya, N. S., Chirikov, V. V., & Shaya, F. T., (2015). COST-EFFECTIVENESS ANA LYSIS OF SOFOSBUVIR BASED COMBINATION THERAPIES AMONG TREATMENT-NAIVE AND PRE-TREATED PATIENTS WITH HEPATITIS C INFECTION. VALUE IN HEALTH , vol.18, no.3.
Gaitonde, P. Et Al. "COST-EFFECTIVENESS ANA LYSIS OF SOFOSBUVIR BASED COMBINATION THERAPIES AMONG TREATMENT-NAIVE AND PRE-TREATED PATIENTS WITH HEPATITIS C INFECTION," VALUE IN HEALTH , vol.18, no.3, 2015
Gaitonde, P. Et Al. "COST-EFFECTIVENESS ANA LYSIS OF SOFOSBUVIR BASED COMBINATION THERAPIES AMONG TREATMENT-NAIVE AND PRE-TREATED PATIENTS WITH HEPATITIS C INFECTION." VALUE IN HEALTH , vol.18, no.3, 2015
Gaitonde, P. Et Al. (2015) . "COST-EFFECTIVENESS ANA LYSIS OF SOFOSBUVIR BASED COMBINATION THERAPIES AMONG TREATMENT-NAIVE AND PRE-TREATED PATIENTS WITH HEPATITIS C INFECTION." VALUE IN HEALTH , vol.18, no.3.
@article{article, author={P. Gaitonde Et Al. }, title={COST-EFFECTIVENESS ANA LYSIS OF SOFOSBUVIR BASED COMBINATION THERAPIES AMONG TREATMENT-NAIVE AND PRE-TREATED PATIENTS WITH HEPATITIS C INFECTION}, journal={VALUE IN HEALTH}, year=2015}